Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012/13 - A rapid epidemiological and virological assessment

Eurosurveillance

Volumn 18, Issue 6, 2013, Pages

  Bragstad, K ^a   Emborg, H D ^a   Fischer, T Kølsen ^a   Voldstedlund, M ^a   Gubbels, S ^a   Andersen, B ^a   Molbak K ^a   Krause, T G ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE;

AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DENMARK; DRUG EFFICACY; FEMALE; GENETIC ANALYSIS; HUMAN; INFLUENZA A (H3N2); INFLUENZA VIRUS A; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PHYLOGENETIC TREE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VIRUS CHARACTERIZATION;

EID: 84873622846     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. European Centre for Disease Prevention and Control (ECDC). Weekly influenza surveillance overview. 1 February 2013. Main surveillance developments in week 4/2013 (21-27 January 2013). Stockholm: ECDC; 2013. Available from: http://ecdc.europa.eu/en/publications/Publications/130201_SUR_Weekly_Influenza_Surveillance_Overview.pdf
2. Grove Krause T, Jakobsen S, Haarh M, Mølbak K. The Danish vaccination register. Euro Surveill. 2012;17(17):pii=20155. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20155 PMid:22551494
3. Emborg H-D, Krause TG, Hviid A, Simonsen J, Mølbak K. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10. BMJ. 2012;344:d7901. http://dx.doi.org/10.1136/bmj.d7901
4. Gubbels S, Krause TG, Bragstad K, Perner A, Mølbak K, Glismann S. Burden and characteristics of influenza A and B in Danish intensive care units during the 2009/10 and 2010/11 influenza seasons. Epidemiol Infect. 2012;1-9 Epub ahead of print]. http://dx.doi.org/10.1017/S0950268812001471
5. Bragstad K, Nielsen LP, Fomsgaard A. The evolution of human influenza A viruses from 1999 to 2006: a complete genome study. Virol J. 2008;5:40. http://dx.doi.org/10.1186/1743-422X-5-40 PMid:18325125 PMCid:2311284
6. Bragstad K, Martel CJ, Thomsen JS, Jensen KL, Nielsen LP, Aasted B, et al. Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades. Influenza Other Respi Viruses. 2011;5(1):13-23. http://dx.doi.org/10.1111/j.1750-2659.2010.00177.x PMid:21138536
7. NetNGlyc 1.0 Server. Center for Biological Sequence Analysis, Technical University of Denmark (DTU), University of Copenhagen. [Accessed 27 Jan 2013]. Available from: http://www.cbs.dtu.dk/services/NetNGlyc/
8. Skowronski DM, Janjua NZ, De Serres G, Dickinson JA, Winter A, Mahmud SM, et al. Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013. Euro Surveill. 201318(5):pii=20394. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20394
9. Centers for Disease Control and Prevention (CDC). Early estimates of seasonal influenza vaccine effectiveness - United States, January 2013. MMWR Morb Mortal Wkly Rep. 2013;62:32-5. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6202a4.htm PMid:23325354
10. Wilson IA, Cox NJ. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol. 1990;8:737-71. http://dx.doi.org/10.1146/annurev.iy.08.040190.003513 PMid:2188678
11. Wiley DC, Wilson IA, Skehel JJ. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature. 1981;289(5796):373-8. http://dx.doi.org/10.1038/289373a0 PMid:6162101
12. McMenamin J, Andrews N, Robertson C, Fleming DM, Durnall H, von Wissmann B, et al. Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13. Euro Surveill. 2013;18(5):pii=20393. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20393
13. Gulati U, Hwang CC, Venkatramani L, Gulati S, Stray SJ, Lee JT, et al. Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). J Virol. 2002;76(23):12274-80. http://dx.doi.org/10.1128/JVI.76.23.12274-12280.2002 PMid:12414967 PMCid:136895
14. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28(10):2731-9. http://dx.doi.org/10.1093/molbev/msr121 PMid:21546353 PMCid:3203626